This large-scale prospective study analyzed data from 13,946 adults in the NHANES III cohort (1988–1994) with up to 12 years of follow-up. It found that even blood lead levels below 0.48 μmol/L (10 μg/dL) were associated with increased all-cause and cardiovascular mortality. Participants in the highest tertile of blood lead
